As the science behind cannabis extraction continues to mature producers have to select between an increasing range of techniques and technologies.
Combining cannabinoids with radiotherapy and smart biomaterials could enhance therapeutic efficacy during the treatment of pancreatic and lung cancers.
Study marks one of the first attempts by U.S. scientists to assess how cannabis with varying concentrations of THC and CBD affect medicinal cannabis users’ feelings of well-being when smoked outside of a laboratory.
Molecular and advanced functional imaging are to be used to compare the brain effects of placebo, THC, and CBD related to attention, memory, processing of novelty and change as well as stress and pain.
Current evidence suggests that medicinal cannabis could be a less dangerous alternative to current drugs on the market.
In a small pilot study, patients using high CBD strains exhibited lower levels of circulating cytokines a marker of inflammation often associated with pain - than those using higher THC products.
The funding will support research to investigate whether medicinal cannabinoid therapies can alleviate symptoms in children with severe autism—and if so, how.